Healthcare Webinars

Food Safety and One Health: transmission of AMR and potentially uropathogenic Escherichia coli (UPEC) from animal sourcesorganised by EFWISG

Annie Pettorelli occupational therapist, will share tips and strategies for managing your brain fog.

Novel medical technologies are being introduced at unprecedented rates, demanding scientific evidence of their safety and efficacy at an unprecedented pace to ensure patient safety and benefit. With success in both in-vitro/in-vivo studies, products are tested on clinical trials assessing use in humans. Predicting low-frequency side effects has been difficult because such side effects may not become apparent until many patients adopt the treatment. When medical devices fail at later stages, financial losses can be catastrophic. Testing on many people is costly, lengthy, and sometimes implausible (e.g., paediatric patients, rare diseases, and underrepresented or hard-to-reach ethnic groups).

One of the most difficult experiences of dealing with addiction in your family is dealing with your own anxiety. We know that anxiety flows through systems like electricity flows through a circuit. It’s contagious, free floating, and it has to land somewhere. If we can work on befriending our own anxiety and regulating our own nervous system, then we put “circuit breakers” into the family system and we invite that in our family members as well. We truly do have power in our family systems just not the way we may have thought. Learning how to be in a healthier relationship to our own anxiety is perhaps the most important things that we can do for our whole families recovery. Who Should Attend this Program? Any family member who has been impacted by a loved one’s substance use disorder will benefit from participating in this webinar. Please note: if you cannot attend the webinar live, please register to receive the recording. Also, this event is Eastern Standard Time.

Join us for a live webinar organized by JoVE on the topic: "Unlocking Gut Movement: Novel Small Bowel Analysis" with Dr. Arthur Beyder Arnaldo Mercado-Perez MD-PhD, Gastroenterologist Mayo Clinic MD-PhD Student Mayo Clinic. Maximizing your experience: The advantages of webinar participation. A detailed description of improved spatial resolution of small bowel transit. Ability to spatially resolve segmentations. Moving past transit measurement by analyzing spatial distribution of contents. An interactive Q&A session with the audience. Temporary full access to the JoVE article discussed in the webinar. Registrants will receive a recording of the webinar. A Certificate of Attendance is available to attendees upon request.

Discover a webinar delving into targeted protein degradation (TPD), an approach using cellular machinery to selectively remove proteins, promising more effective treatments with minimized side effects. The classical small molecule drug discovery strategies are inhibiting the biological function of proteins of interest, which either block the active pocket or change the protein conformation. However, the significant disadvantages such as limitations in target candidates, dose issues and quick resistance foundations, are calling for a more preferable therapy with fewer side effects. TPD, a strategy that utilizes the native protein homeostasis (or proteostasis) machinery to deplete proteins of interest (POI), represents a novel and promising therapeutic approach.

Speaker Dr. Guillermo Ponce de León Ballesteros Moderator Dr. Sebastián Arana Garza Panelists: Dr. Mariano Palermo Dr. Luciano Poggi

The Cell Type Taxonomies A-Z: Webinar Series features presentations by Allen Institute scientists & staff for a full guide to brain cell types and taxonomies, and how and why to use these resources in your research. Jan 10, 2024 - May 22, 2024 Virtual Time 10:00AM PST Audience Graduate, Postdocs, Scientists, Undergraduate See agenda and learn more about speakers

Discover an informative webinar focused on maintaining regulatory compliance with a high-quality reference standard program for pharmaceutical development. This webinar is designed for industry professionals looking to gain a practical understanding of reference standards, from their acquisition and qualification to their application in maintaining product quality and regulatory compliance.

CEO Amir Reichman will review Scinai’s 2023 accomplishments and discuss 2024 plans, including bringing Scinai’s anti-IL-17 VHH antibody (‘NanoAb’) innovative psoriasis treatment into clinical trials by the end of 2024.